Case Reports in Immunology最新文献

筛选
英文 中文
Pernicious Anemia in an Adult with Trisomy 21. 成人21三体的恶性贫血
IF 1
Case Reports in Immunology Pub Date : 2023-01-01 DOI: 10.1155/2023/2747756
Kentaro Kamada, Osamu Kawano, Satoshi Yakuwa, Kentaro Wakasa, Kimiaki Uetake
{"title":"Pernicious Anemia in an Adult with Trisomy 21.","authors":"Kentaro Kamada,&nbsp;Osamu Kawano,&nbsp;Satoshi Yakuwa,&nbsp;Kentaro Wakasa,&nbsp;Kimiaki Uetake","doi":"10.1155/2023/2747756","DOIUrl":"https://doi.org/10.1155/2023/2747756","url":null,"abstract":"<p><p>Pernicious anemia is an autoimmune disease caused by the malabsorption of vitamin B12. It usually appears in the elderly. People with trisomy 21 are susceptible to autoimmune diseases. This susceptibility is thought to be due to altered expression of the <i>AIRE</i> gene, which is located in the 21q22.3 region. Although pernicious anemia is not common in people with trisomy 21, <i>AIRE</i> is pointed out as a susceptibility gene of pernicious anemia in a genome-wide association study. Here, we report a man with trisomy 21, who suffered from the pernicious anemia. When he was in his 30 s, he visited our hospital because of diarrhea and poor oral intake. He showed thrombocytopenic purpura-like features, and was diagnosed as pernicious anemia. After supplementation of vitamin B12, he recovered from the illness. The reason for his early onset may be because of trisomy 21. Altered expression of <i>AIRE</i> might trigger the disease.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2023 ","pages":"2747756"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10208237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Child with Cystic Fibrosis. 囊性纤维化儿童嗜酸性粒细胞增多和全身症状综合征的药物反应
IF 1
Case Reports in Immunology Pub Date : 2023-01-01 DOI: 10.1155/2023/1006376
Ahmed Abushahin, Haneen Toma, Sara G Hamad, Mutasim Abu-Hasan
{"title":"Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Child with Cystic Fibrosis.","authors":"Ahmed Abushahin,&nbsp;Haneen Toma,&nbsp;Sara G Hamad,&nbsp;Mutasim Abu-Hasan","doi":"10.1155/2023/1006376","DOIUrl":"https://doi.org/10.1155/2023/1006376","url":null,"abstract":"<p><strong>Background: </strong>Drug reaction with eosinophilia and systemic symptoms (DRESSs) syndrome is an idiosyncratic drug-induced reaction that rarely occurs in children but can lead to serious complications. It manifests most commonly with fever, extensive skin eruptions, and eosinophilia. Symptoms typically develop two to six weeks after the initiation of the inciting drug. Visceral organ involvement especially the liver can also occur and if not recognized early and the inciting drug is not stopped immediately, it can lead to liver failure. Therefore, early diagnosis is important but can be very challenging because of disease rarity, lack of a diagnostic test, and its overlap with other common pediatric allergic and infectious conditions. <i>Case Presentation</i>. A 2.5-year-old boy with known diagnosis of cystic fibrosis, bilateral bronchiectasis, pancreatic insufficiency, and chronic airway colonization with <i>Pseudomonas aeruginosa</i> was admitted to our hospital with acute pulmonary exacerbation of CF lung disease. He was treated with intravenous piperacillin-tazobactam and intravenous amikacin in addition to airway clearance. On day 18 of treatment, the patient developed high grade fever followed by diffuse erythematous and pruritic maculopapular rash. Blood tests showed high eosinophilia, high C-reactive protein (CRP), and high liver enzymes levels. The clinical features and the laboratory findings were consistent with the DRESS syndrome. Therefore, all antibiotics were discontinued. Progressive resolution of the symptoms was observed within two days. Laboratory abnormalities were also normalized in the follow-up clinic visit 4 months later.</p><p><strong>Conclusion: </strong>Our case demonstrates the importance of early recognition of the DRESS syndrome in children who develop fever and skin rashes with eosinophilia while undergoing long-term antibiotic treatment. Prompt discontinuation of the offending drug is the cornerstone therapy and results in the resolution of symptoms and prevention of serious complications.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2023 ","pages":"1006376"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10697998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An Extraordinary Case of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) Syndrome Misdiagnosed as Juvenile Idiopathic Arthritis on Admission. 自身免疫性多内分泌病变-念珠菌病-外胚层营养不良(APECED)综合征在入院时误诊为幼年特发性关节炎一例。
IF 1
Case Reports in Immunology Pub Date : 2023-01-01 DOI: 10.1155/2023/2363760
Gulcin Aytac, Burcu Guven, Ilyas Aydin, Ezgi Topyildiz, Ayca Aykut, Asude Durmaz, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer
{"title":"An Extraordinary Case of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) Syndrome Misdiagnosed as Juvenile Idiopathic Arthritis on Admission.","authors":"Gulcin Aytac,&nbsp;Burcu Guven,&nbsp;Ilyas Aydin,&nbsp;Ezgi Topyildiz,&nbsp;Ayca Aykut,&nbsp;Asude Durmaz,&nbsp;Neslihan Edeer Karaca,&nbsp;Guzide Aksu,&nbsp;Necil Kutukculer","doi":"10.1155/2023/2363760","DOIUrl":"https://doi.org/10.1155/2023/2363760","url":null,"abstract":"<p><strong>Background: </strong>APECED is a syndrome characterized by autoimmune polyendocrinopathy, candidiasis, and ectodermal dystrophy. The most observed clinical findings are chronic mucocutaneous candidiasis, hypoparathyroidism, and autoimmune adrenal insufficiency. <i>Case Presentation</i>. A three-year-old male patient was admitted with classical signs of juvenile idiopathic arthritis and treated with nonsteroidal anti-inflammatory drugs. During follow-up, signs of autoimmunity, candidiasis, nail dystrophy, and onychomycosis were observed. The parents were consanguineous, and targeted next-generation sequencing was performed. A homozygous mutation in the AIRE gene SAND domain (c.769C > T, p.Arg257Ter) was detected, and the patient was diagnosed with APECED syndrome.</p><p><strong>Conclusion: </strong>Inflammatory arthritis is rarely described in association with APECED and is often misdiagnosed as juvenile idiopathic arthritis. In APECED cases, nonclassical symptoms such as arthritis may occur before developing classical symptoms and considering the diagnosis of APECED in patients with CMC and arthritis is useful for early diagnosis before development of complications and management of disease.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2023 ","pages":"2363760"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9415144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult-Onset Still's Disease with Dermatopathic Lymphadenitis Clinicopathologic Features: A Rare Case Report and Review of the Literature 成人发病的斯蒂尔氏病伴皮肤病性淋巴结炎的临床病理特征:罕见病例报告及文献复习
IF 1
Case Reports in Immunology Pub Date : 2022-06-03 DOI: 10.1155/2022/1653683
Reda Elhawary, M. Nadeem, M. Abdelwahed, Mansour Somaily, Shahenda Y. Alemam
{"title":"Adult-Onset Still's Disease with Dermatopathic Lymphadenitis Clinicopathologic Features: A Rare Case Report and Review of the Literature","authors":"Reda Elhawary, M. Nadeem, M. Abdelwahed, Mansour Somaily, Shahenda Y. Alemam","doi":"10.1155/2022/1653683","DOIUrl":"https://doi.org/10.1155/2022/1653683","url":null,"abstract":"Adult-onset Still's disease (AOSD) is an inflammatory disorder characterized by fever, arthritis, and a transient skin rash. It is a rare condition characterized by inflammatory multisystem changes of unknown cause. A 35-year-old woman was admitted to rheumatology department of tertiary care hospital complaining of painful wrist and skin rash as well as fever, generalized lymphadenopathy, weight loss, and fatigue. The early diagnosis of AOSD was confirmed by clinical history, examination, and laboratory tests, as well as a confirmatory skin biopsy with typical histopathological features, namely, upper epidermal dyskeratosis and dermal inflammatory neutrophilic infiltration. The patient's condition was treated with steroids and NSAIDs, to which she responded well, and on follow-up, her symptoms regressed along with improvement in biochemical parameters. The authors suggest that skin biopsy and confirmation of histopathological diagnosis of AOSD are useful in the diagnosis and proper management of AOSD patients in cases with clinical suspicion of AOSD.","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"40 1","pages":""},"PeriodicalIF":1.0,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76666801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis 成人脑膜炎球菌败血症患者终末补体途径缺乏
IF 1
Case Reports in Immunology Pub Date : 2022-05-23 DOI: 10.1155/2022/9057000
F. Staels, W. Meersseman, P. Stordeur, K. Willekens, S. Van Loo, A. Corveleyn, I. Meyts, G. Meyfroidt, R. Schrijvers
{"title":"Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis","authors":"F. Staels, W. Meersseman, P. Stordeur, K. Willekens, S. Van Loo, A. Corveleyn, I. Meyts, G. Meyfroidt, R. Schrijvers","doi":"10.1155/2022/9057000","DOIUrl":"https://doi.org/10.1155/2022/9057000","url":null,"abstract":"The complement system is an essential part of our innate immune system. Three enzymatic activation pathways are described, all converging into a common terminal pathway which causes lysis of the target cell. Late complement deficiencies (LCDs) are typically diagnosed in children or adolescents with invasive meningococcal disease (IMD). However, IMD can also be a first manifestation in adulthood and should prompt for the evaluation of the LCD. We report the case of a young adult with IMD who was found to have a LCD, caused by a compound heterozygous mutation in C6. His vaccination status was optimized and prophylactic antibiotic treatment was initiated. By means of this case, we would like to raise awareness of underlying LCD in (young) adults presenting with IMD by N. meningitidis. Screening for complement deficiencies after IMD, followed by genetic testing, can be lifesaving and allows for genetic counselling. In addition, we discuss the diagnosis and treatment of LCD.","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"40 1","pages":""},"PeriodicalIF":1.0,"publicationDate":"2022-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85003434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Case of Anti-SAE1 Dermatomyositis 抗sae1皮肌炎1例
IF 1
Case Reports in Immunology Pub Date : 2022-03-04 DOI: 10.1155/2022/9000608
Max de Vries, M. Schreurs, Els J. M. Ahsmann, Marcela Spee-Dropková, Faiz Karim
{"title":"A Case of Anti-SAE1 Dermatomyositis","authors":"Max de Vries, M. Schreurs, Els J. M. Ahsmann, Marcela Spee-Dropková, Faiz Karim","doi":"10.1155/2022/9000608","DOIUrl":"https://doi.org/10.1155/2022/9000608","url":null,"abstract":"Introduction Anti-SAE1 antibodies have a low prevalence in dermatomyositis patients. Case Description. A 61-year-old woman presented with progressive shortness of breath, arthralgia, heliotrope rash, Gottron's papules, and erythematous rash. She had an interstitial lung disease (ILD) with a significant decrease in lung function. There was no muscle involvement. Immunological laboratory test results showed strongly positive anti-SAE1 antibodies. Glucocorticoid treatment resulted in remission of dermatomyositis. Conclusion Anti-SAE antibodies in dermatomyositis patients are closely linked to unique clinical features.","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"175 1","pages":""},"PeriodicalIF":1.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72636527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Novel MAGT1 Mutation Found in the First Chinese XMEN in Hong Kong. 在香港第一批中国XMEN中发现新的MAGT1突变。
IF 1
Case Reports in Immunology Pub Date : 2022-02-14 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2390167
Elaine Yuen Ling Au, Edmund Kwok Kwan Tung, Ricky Wai Ki Ip, Philip Hei Li
{"title":"Novel <i>MAGT1</i> Mutation Found in the First Chinese XMEN in Hong Kong.","authors":"Elaine Yuen Ling Au,&nbsp;Edmund Kwok Kwan Tung,&nbsp;Ricky Wai Ki Ip,&nbsp;Philip Hei Li","doi":"10.1155/2022/2390167","DOIUrl":"https://doi.org/10.1155/2022/2390167","url":null,"abstract":"<p><p>The availability of next-generation sequencing (NGS) helps to resolve many of the diagnostic odysseys. Common variable immunodeficiency disease (CVID) is an entity encompassing a heterogenous group of conditions with hypogammaglobulinemia, and it is a diagnosis of exclusion. In recent years, with the advances of molecular diagnostics, more and more patients have been reclassified with more defined entities after their genetic causes were found. Here, we reported a young man, who was managed as CVID since childhood, presenting with recurrent infection, hypogammaglobulinemia, and immune thrombocytopenia (ITP). Finally, more than a decade after initial presentation, gene panel testing revealed a novel mutation in the MAGT1 gene. Collectively, the genetic findings and clinical presentations confirm the diagnosis of X-linked immunodeficiency with magnesium defect and Epstein-Barr virus infection and neoplasia (XMEN). MAGT1 is an evolutionarily conserved, magnesium-specific transporter expressed in all mammalian cells that plays an essential role in magnesium homeostasis. MAGT1 also acts as an accessory protein for STT3B, as catalytic subunits of the oligosaccharyltransferase protein complex, which carries out glycan chain transfer to proteins in the endoplasmic reticulum during N-glycosylation. Glycans play an essential role in the stability, maturation, and localization in glycoproteins that are important in our immune cells' function. Mutation of the gene resulted in a rare X-linked recessive condition XMEN. The disease has complete penetrance but variable expressivity. It is mainly associated with immunodeficiency, immunodysregulation, and predisposition to EBV-associated lymphoproliferation. Extraimmune manifestations have also been reported in some patient cohorts, including hepatic and neurological abnormalities. Overall, the presentation varies among patients and overlaps with other clinical entities, in which diagnosis is challenging. Before the era of NGS, traditional workup hinges heavily on phenotype studies, followed by single-gene sequencing. The diagnostic yield is low, and a significant delay in diagnosis is common. This case illustrated the importance of early consideration of molecular studies in complex immunological cases without obvious secondary causes as an integral part of patient management.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2022 ","pages":"2390167"},"PeriodicalIF":1.0,"publicationDate":"2022-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39659259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction. 尽管GM-CSF抗体降低,肺泡蛋白沉积症对血浆置换和利妥昔单抗难治性。
IF 1
Case Reports in Immunology Pub Date : 2022-01-30 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2104270
Aysenur Keske, Eric M Destrampe, Byron Barksdale, William N Rose
{"title":"Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction.","authors":"Aysenur Keske,&nbsp;Eric M Destrampe,&nbsp;Byron Barksdale,&nbsp;William N Rose","doi":"10.1155/2022/2104270","DOIUrl":"https://doi.org/10.1155/2022/2104270","url":null,"abstract":"<p><p>We share our experience of a patient with pulmonary alveolar proteinosis who was refractory to plasmapheresis and rituximab despite a significant reduction in the offending antibody. He presented with shortness of breath, fevers, chills, and sweats for 4 months. He was diagnosed with autoimmune PAP based on typical radiology findings, bronchoalveolar fluid analysis, and elevated anti-GM-CSF levels. Given his limited improvement with whole lung lavage and inhaled GM-CSF therapy, he underwent two series of plasmapheresis. Series one was 5 procedures in 6 days, and series two was 5 procedures in 9 days followed by rituximab. These did not appear to provide any lasting clinical benefit in the year after plasmapheresis despite a marked decrease in serum anti-GM-CSF levels. However, about a year after plasmapheresis, he went into remission and has not required any treatment.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2022 ","pages":"2104270"},"PeriodicalIF":1.0,"publicationDate":"2022-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39609485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature. 小细胞肺癌患者在阿特唑单抗治疗期间免疫检查点抑制剂诱导的边缘脑炎:一个病例报告和文献回顾
IF 1
Case Reports in Immunology Pub Date : 2022-01-06 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9290922
Koki Nakashima, Yoshiki Demura, Kosuke Kurokawa, Toshihiro Takeda, Norihiro Jikuya, Masahiro Oi, Toshihiko Tada, Masaya Akai, Tamotsu Ishizuka
{"title":"Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature.","authors":"Koki Nakashima,&nbsp;Yoshiki Demura,&nbsp;Kosuke Kurokawa,&nbsp;Toshihiro Takeda,&nbsp;Norihiro Jikuya,&nbsp;Masahiro Oi,&nbsp;Toshihiko Tada,&nbsp;Masaya Akai,&nbsp;Tamotsu Ishizuka","doi":"10.1155/2022/9290922","DOIUrl":"https://doi.org/10.1155/2022/9290922","url":null,"abstract":"<p><p>Paraneoplastic neurological syndrome (PNS) is associated with malignancies, including small-cell lung cancer. Recently, PNS cases among patients with small-cell lung cancer (SCLC) induced by immune checkpoint inhibitors have increased. We herein report a 66-year-old man with SCLC who developed disorientation, dysphagia, and gait disturbance after three courses of treatment with atezolizumab. Brain magnetic resonance imaging revealed a high-intensity area in the bilateral temporal lobes. Blood test results were positive for anti-Hu and anti-Zic4 antibodies, which led to the diagnosis of limbic encephalitis as PNS. Some symptoms improved with intravenous administration of steroids and immunoglobulins.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2022 ","pages":"9290922"},"PeriodicalIF":1.0,"publicationDate":"2022-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39825672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Clinical and Genetic Findings of the First Report of PAPA Syndrome in Brazil. 巴西PAPA综合征首次报告的临床和遗传学发现。
IF 1
Case Reports in Immunology Pub Date : 2021-12-13 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6660937
Sérgio Júlio Fernandes, Maria Isabel Valdomir Nadaf, Nauro Hudson Monteiro, Izabel Nazira Nadaf, Cleiton Ribeiro Lélis, Bianca Yumi Takano, Bárbarah Gabriella de Camargo Monteiro, Nyvea Gabriella de Camargo Monteiro, Olga Akiko Takano, Leonardo Oliveira Mendonça
{"title":"Clinical and Genetic Findings of the First Report of PAPA Syndrome in Brazil.","authors":"Sérgio Júlio Fernandes,&nbsp;Maria Isabel Valdomir Nadaf,&nbsp;Nauro Hudson Monteiro,&nbsp;Izabel Nazira Nadaf,&nbsp;Cleiton Ribeiro Lélis,&nbsp;Bianca Yumi Takano,&nbsp;Bárbarah Gabriella de Camargo Monteiro,&nbsp;Nyvea Gabriella de Camargo Monteiro,&nbsp;Olga Akiko Takano,&nbsp;Leonardo Oliveira Mendonça","doi":"10.1155/2021/6660937","DOIUrl":"https://doi.org/10.1155/2021/6660937","url":null,"abstract":"<p><strong>Background: </strong>PAPA syndrome (MIM #604416) is a rare monogenic autoinflammatory disease genetically transmitted in an autosomal dominant trait that results from missense mutations in the proline-serine-threonine phosphatase-interactive protein 1 (PSTPIP1) gene located on chromosome 15 and is characterized by sterile pyogenic arthritis, pyoderma gangrenosum, and cystic acne. We describe the clinical and molecular findings of two related Brazilian patients with PAPA syndrome. <i>Case Presentation</i>. A 7-year-and-3-month-old boy with nonconsanguineous parents had had recurrent pyoarthritis since the age of 5 years and 8 months. During his last and long hospitalization, the lack of improvement with antibiotics, evidence of increased inflammatory activity, repeated arthrotomies, draining purulent fluid that had negative cultures, and the history of trauma, all on in a clinical background of pyoarthritis, led to the suspicion of an autoinflammatory syndrome. This was confirmed by the good clinical response to corticotherapy. Genetic sequencing confirmed the diagnosis of PAPA syndrome, with the pathogenic mutation c.688 G > <i>A</i> (p. Ala230Thr) in the PSTPIP1 gene present in the patient and in the mother.</p><p><strong>Conclusions: </strong>This case illustrates that in children with recurrent/recalcitrant sterile recurrent pyogenic arthritis/osteomyelitis, the possibility of an underlying immunological condition should be considered. In both, recurrent infections or recurrent inflammation, many genes involved in the inborn errors of immunity can be associated, and a correct and precocious diagnosis is necessary to avoid mobility and mortality. To the best of our knowledge, this is the first report of PAPA syndrome in Brazil.</p>","PeriodicalId":42865,"journal":{"name":"Case Reports in Immunology","volume":"2021 ","pages":"6660937"},"PeriodicalIF":1.0,"publicationDate":"2021-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39611058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信